GLP-1 Refill Form Template

A structured follow-up form for existing GLP-1 patients requesting a prescription refill. Captures current biometrics, injection history, recent health changes, and any new medications or surgeries since the last visit. Designed to give prescribers the clinical context needed to safely renew GLP-1 prescriptions and adjust dosing as needed.

3 sections
10 fields
HIPAA-ready
2 citations

Free Template

GLP-1 Refill Form

Preview Form Automate This Form
No account required to use template
Customize with your practice branding
Reviewed against HIPAA & DEA guidelines

Form Preview

This is how the form appears to patients. Customize with your practice name and branding.

Your Practice Name

GLP-1 Refill Form

Preview
1

Current Biometrics

Please provide your most recent measurements.

What is your current height (in inches)?

e.g. 68

What is your current weight (in pounds)?

e.g. 210

2

Injection History

Tell us about your recent GLP-1 use.

Are you actively taking or have you recently taken any GLP-1 medications?

Yes
No

If yes, when was your last injection date?

If yes, how many units was your last injection?

e.g. 0.25

If yes, how many months have you been taking GLP-1 medications?

e.g. 3

3

Health Changes

Please let us know about any changes to your health since your last visit.

Since we last saw you, have you started any new medications, had any surgeries, or had any significant changes to your health?

Yes
No

If yes, please share the details.

Describe any new medications, surgeries, or health changes...

Is there anything else the practitioner should be made aware of?

Yes
No

If yes, please share the details.

Any additional information for your provider...

Preview only. Your live form will include your branding and e-signature capture.

Submit

Compliance & Regulatory Notes

Review these notes before deploying this form in your practice.

GLP-1 refill prescriptions require documented follow-up evaluation. Prescribers should review weight change since last visit, any new contraindications, and adverse event history before renewing. See FDA semaglutide labeling: https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/215256s000lbl.pdf

New medications reported since last visit should be screened for interactions, particularly insulin, sulfonylureas, and other glucose-lowering agents which can increase hypoglycemia risk when combined with GLP-1 agonists.

Want This Form Automated?

Karpa Health turns static intake forms into a fully automated clinical workflow. Branded, HIPAA-compliant, and connected to compounding pharmacies.

  • Branded intake on your website
  • AI contraindication screening
  • One-click prescribing to pharmacies
  • Automated refill management
  • E-signatures and HIPAA audit trail
  • 50-state provider network included
Book a Demo

Free 30-minute walkthrough

Sources & References

  1. FDA Semaglutide (Wegovy) Prescribing Information
  2. AACE/ACE Obesity Clinical Practice Guidelines

Frequently Asked Questions

How often should GLP-1 patients complete a refill form?

A follow-up form should be completed at each refill visit, typically every 4 to 12 weeks depending on the program structure. Regular check-ins allow prescribers to monitor weight progress, adjust dosing, and identify any new health changes or drug interactions.

What triggers a full intake instead of a refill form?

If a patient reports new medications, surgeries, significant health changes, or has been off therapy for more than 90 days, a full intake form should be completed in place of the refill form to ensure no new contraindications have developed.